{
    "title": "PharmaMar shares soar after drug study suggests efficacy against Omicron",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10390443/PharmaMar-shares-soar-drug-study-suggests-efficacy-against-Omicron.html",
    "date": "2022-01-11",
    "keywords": [
        "drug",
        "pharmamar",
        "covid19",
        "plitidepsin",
        "company",
        "phase",
        "treatment",
        "year",
        "note",
        "opportunity",
        "jan",
        "tuesday",
        "drugmaker",
        "omicron",
        "life",
        "science",
        "alliance",
        "journal",
        "aplidin",
        "effect",
        "load",
        "animal",
        "lung",
        "tissue",
        "paper",
        "cancer",
        "iii",
        "hypothesis",
        "activity",
        "chairman",
        "sousa",
        "statement",
        "afternoon",
        "trade",
        "track",
        "day",
        "january",
        "news",
        "alvaro",
        "analyst",
        "brokerage",
        "alantra",
        "caution",
        "effectiveness",
        "coronavirus",
        "covid",
        "administration",
        "pfizer",
        "merck",
        "co",
        "lenze",
        "market",
        "reaction",
        "rally",
        "stock",
        "reporting",
        "landauro",
        "nathan",
        "allen",
        "jes\u00fas",
        "aguado",
        "louise",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}